ClinVar Miner

Submissions for variant NM_001033855.3(DCLRE1C):c.47T>C (p.Ile16Thr)

gnomAD frequency: 0.00001  dbSNP: rs1317003987
Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 4
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
ClinGen Severe Combined Immunodeficiency Variant Curation Expert Panel, ClinGen RCV001381226 SCV004102784 likely pathogenic Severe combined immunodeficiency due to DCLRE1C deficiency 2023-11-14 reviewed by expert panel curation The c.47T>C (NM_001033855.3) variant in DCLRE1C is a missense variant predicted to cause substitution of Isoleucine by Tryptophan at amino acid 16 (p.Ile16Thr). This variant is absent from gnomAD v2.1.1 (PM2_Supporting). Activity levels in % of WT activity = Recombination: Mean (SD): 79.67 (0.27) and DNA repair (36h after IR): Mean (SD): 80.11 (18.11). The results are bigger than our established threshold for abnormal results (defined as <25% of wild-type activity). Thus, PS3 is NOT Met (PMID: 25917813). At least one patient with this variant displayed Diagnostic criteria for SCID: 0.5pts + T-B-NK+ lymphocyte subset profile: 0.5 pts + Increased cellular radiosensitivity: 0.5pts = Total 1.5 pts, PP4 met, which is highly specific for SCID (PP4 Met) PMIDs: 15770702 and 25917813. Not reported in the literature, but this variant was identified in one patient at Invitae with a clinical diagnosis of SCID (0.5 pts) + a 207 genes immunodeficiency panel ordered, which included all known SCID genes (0.5 points) + severe T and B cell lymphopenia with normal NK cells (CD3: 13, CD19: 0, CD56: 753), consistent with T-B-NK+ SCID (0.5 pts) = totalizing 1.5 pts, PP4 met. Patient 5 is a compound heterozygous with S119X (Pathogenic according to the SCID VCEP specifications, 1 pt, PM3 Met. PMID: 15770702). Not reported in the literature, but this variant was identified in one patient at Invitae with a clinical diagnosis of SCID. In this patient, the variant co-occurred - in trans - confirmed by parental testing - with DCLRE1C deletion (Exons 1-3), pathogenic according to the SCID VCEP specifications: 1 pt. Total: 1+1: 2 pts, PM3_Strong. In summary, this variant meets the criteria to be classified as Likely Pathogenic for autosomal recessive SCID based on the ACMG/AMP criteria applied, as specified by the ClinGen SCID VCEP. Criteria applied: PM3_Strong, PM2_supporting, PP4 (VCEP specifications version 1).
Invitae RCV001381226 SCV001579530 pathogenic Severe combined immunodeficiency due to DCLRE1C deficiency 2024-01-19 criteria provided, single submitter clinical testing This sequence change replaces isoleucine, which is neutral and non-polar, with threonine, which is neutral and polar, at codon 16 of the DCLRE1C protein (p.Ile16Thr). This variant is not present in population databases (gnomAD no frequency). This missense change has been observed in individual(s) with severe combined immunodeficiency (PMID: 15770702; Invitae). In at least one individual the data is consistent with being in trans (on the opposite chromosome) from a pathogenic variant. ClinVar contains an entry for this variant (Variation ID: 1069380). An algorithm developed to predict the effect of missense changes on protein structure and function (PolyPhen-2) suggests that this variant is likely to be disruptive. Experimental studies have shown that this missense change affects DCLRE1C function (PMID: 15770702, 25917813). For these reasons, this variant has been classified as Pathogenic.
Women's Health and Genetics/Laboratory Corporation of America, LabCorp RCV003323874 SCV004028835 uncertain significance not specified 2023-07-11 criteria provided, single submitter clinical testing Variant summary: DCLRE1C c.47T>C (p.Ile16Thr) results in a non-conservative amino acid change located in the metallo-beta-lactamase domain (Musio_2005, Felgentreff_2015) of the encoded protein sequence. Five of five in-silico tools predict a damaging effect of the variant on protein function. The variant was absent in 251244 control chromosomes (gnomAD v2.1, Exomes dataset). c.47T>C has been reported in the literature in at least two compound heterozygous individuals affected with Severe Combined Immunodeficiency (e.g., Musio_2005, Felgentreff_2015, Cowan_2022). These data indicate that the variant may be associated with disease. At least two publications report experimental evidence evaluating an impact on protein function, finding that the variant results in an approximately 20% reduction in recombination activity and DNA repair activity relative to wild-type in vitro (e.g., Musio_2005, Felgentreff_2015). The following publications have been ascertained in the context of this evaluation (PMID: 25917813, 15770702, 36546626). One submitter has reported clinical-significance assessments for this variant to ClinVar after 2014, citing overlapping evidence, and has classified the variant as pathogenic. Based on the evidence outlined above, the variant was classified as VUS-possibly pathogenic.
Baylor Genetics RCV003462975 SCV004190891 pathogenic Histiocytic medullary reticulosis 2023-09-24 criteria provided, single submitter clinical testing

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.